YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Readiness to Disclose Mother's HIV Diagnosis to Their Children in Beijing, China
Not Applicable
Completed
- Conditions
- HIV
- Interventions
- Behavioral: disclosure-support counseling intervention
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5
- Registration Number
- NCT03248778
- Locations
- 🇨🇳
Beijing Ditan Hospital, Beijing, China
Effects of Flavors on Nicotine Reinforcement in Smokers
Early Phase 1
Completed
- Conditions
- Nicotine Dependence
- Interventions
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT03243630
- Locations
- 🇺🇸
Veterans Affairs, West Haven, Connecticut, United States
Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy
Phase 1
Completed
- Conditions
- Post-Prandial HyperglycemiaPost-Prandial Hypoglycemia
- Interventions
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 15
- Registration Number
- NCT03234491
- Locations
- 🇺🇸
Yale Diabetes Research Clinic, New Haven, Connecticut, United States
Yale Wellness Project
Not Applicable
Completed
- Conditions
- Mental Health Wellness 1
- Interventions
- Behavioral: Emotional IntelligenceBehavioral: Mindfulness-Based Stress ReductionBehavioral: Sudarshan Kriya Yoga
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 300
- Registration Number
- NCT03229577
- Locations
- 🇺🇸
Yale Center for Emotional Intelligence, New Haven, Connecticut, United States
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Phase 1
Terminated
- Conditions
- Delta-9-TetrahydroncannabinolBipolar DisorderHealthy Controls
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Yale University
- Target Recruit Count
- 2
- Registration Number
- NCT03206463
- Locations
- 🇺🇸
Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States
Sugammadex and Decreased Time to Extubation
Phase 4
Completed
- Conditions
- Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery
- Interventions
- Other: Placebo
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Yale University
- Target Recruit Count
- 90
- Registration Number
- NCT03196167
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Completed
- Conditions
- IGT - Impaired Glucose ToleranceT2D
- Interventions
- Diagnostic Test: Oral Glucose Tolerance TestDiagnostic Test: Hyperglycemic ClampDiagnostic Test: Isoglycemic Intravenous Glucose TestDiagnostic Test: Hyperinsulinemic Euglycemic Clamp and 2H20
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 100
- Registration Number
- NCT03195400
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Utilization of Somatic Tissue Oxygen Saturation Monitoring in Pregnant Women
Not Applicable
Withdrawn
- Conditions
- Pre-Eclampsia
- Interventions
- Diagnostic Test: StO2 and EndoPAT
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2019-07-12
- Lead Sponsor
- Yale University
- Registration Number
- NCT03196141
- Locations
- 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States
Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
Early Phase 1
Completed
- Conditions
- Marijuana Impairment
- Interventions
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT03191084
- Locations
- 🇺🇸
Olin Neuropsychiatry Research Center, Hartford, Connecticut, United States
Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)
Not Applicable
Completed
- Conditions
- Mood Disorders
- Interventions
- Behavioral: BE-SMART
- First Posted Date
- 2017-06-12
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Yale University
- Target Recruit Count
- 76
- Registration Number
- NCT03183388
- Locations
- 🇺🇸
Mood Disorders Research Program, Yale School of Medicine, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath